ADMS - Adamas Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts991010
Avg. Estimate-0.98-0.93-3.79-2.45
Low Estimate-1.1-1.07-4.29-3
High Estimate-0.82-0.84-3.46-1.62
Year Ago EPS-1.26-1.22-4.87-3.79
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts991010
Avg. Estimate12.84M14.26M55.42M98.9M
Low Estimate12.34M13.5M52M75M
High Estimate13.6M15.7M60.97M166.08M
Year Ago Sales7.57M10.61M34.05M55.42M
Sales Growth (year/est)69.70%34.40%62.80%78.50%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-1.41-1.34-1.34-1.15
EPS Actual-1.26-1.22-1.06-1.08
Difference0.150.120.280.07
Surprise %10.60%9.00%20.90%6.10%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.98-0.93-3.79-2.45
7 Days Ago-0.98-0.93-3.79-2.45
30 Days Ago-1-0.95-3.87-2.39
60 Days Ago-1.12-1.07-4.28-2.52
90 Days Ago-1.12-1.07-4.28-2.52
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days122N/A
Up Last 30 Days88106
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesADMSIndustrySectorS&P 500
Current Qtr.22.20%N/AN/A0.02
Next Qtr.23.80%N/AN/A0.04
Current Year22.20%N/AN/A0.05
Next Year35.40%N/AN/A0.10
Next 5 Years (per annum)32.20%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A